MOUNTAIN VIEW, Calif., March 21, 2016 /PRNewswire/ -- Based on its recent study of the brain volumetric image analysis market, Frost & Sullivan recognises Brainreader ApS with the 2016 European Frost & Sullivan Award for Enabling Technology Leadership. The Denmark-based Brainreader ApS has won this honour for developing a novel Software as a Service (SaaS) solution, the NEUROREADER™ that performs rapid assessment and measurement of brain volume changes. The tool is very effective in identifying early changes in brain volumes.
Magnetic resonance imaging (MRI) scans from multiple persons can vary due to differences in slice orientation and brain features. Such images are normalised to a standard template image by a process known as spatial normalisation. After normalisation, the images are manually segmented by comparing an image to a template. Technology developers have now developed an automatic segmentation procedure that digitally compares at least two different images. Brainreader has improved upon this solution by introducing NEUROREADER™, a software that can automate the entire process and provide accurate assessment of brain volume. This is necessary in the diagnosis of various cerebro-neural diseases such as Alzheimer's disease (AD).
"NEUROREADER™ is a fully automated volume measurement solution that employs a multi-atlas-based segmentation procedure to analyse different brain structures," said Frost & Sullivan Research Analyst Darshana De. "This approach delivers optimal analysis by identifying changes in brain volume associated with neurodegenerative diseases and traumatic brain injuries. Radiologists and researchers alike can use the software to detect abnormalities in the brain and study various brain conditions such as depression and concussion."
NEUROREADER™ can map MRI scans of patients' brains against a large Food & Drug Administration (FDA)-cleared database of brain MRIs of healthy individuals, in just a few minutes. NEUROREADER™, at present, is the only software of its kind to have received a fully FDA 510(k) clearance, as well as a CE Class I medical device certification for using a normative database and statistical evaluation of the measured volumes.
"Apart from AD, NEUROREADER™ solution can be used to study neurological brain disorders such as mild traumatic brain injury, which causes volume changes in the brain," noted Darshana. "The solution can also be highly effective in distinguishing patients with psychiatric disorders with symptoms similar to AD from those suffering from AD itself."
Significantly, the NEUROREADER™ is easy to use and can integrate with almost all picture archiving and communication systems (PACS). It is a software-as-a-service product, which is sold either through a subscription or on a pay-per-use basis.
For NEUROREADER™'s long-term viability and impact on the brain volumetric image analysis market, Brainreader ApS richly deserves the 2016 European Frost & Sullivan Award for Enabling Technology Leadership.
Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also stokes the development of newer products and applications. The award recognises the high market acceptance potential of the recipient's technology.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Brainreader ApS
Brainreader is a Danish company, experienced in medical device and software development. The product NEUROREADER™ is a reliable, easy-to-use and cost-effective technology that brings objectivity into the clinical practice.
Brainreader are collaborating closely with high profile physicians in Europe and the U.S. to ensure their product design focuses on usability and integration into the clinical workflow. The team behind NEUROREADER™ has interest in improving the toolbox for physicians and make a difference for patients with neurological diseases.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
P: 210. 247.3870
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/frost--sullivan-commends-brainreader-for-developing-a-solution-that-automates-the-entire-process-of-brain-disease-diagnosis-300238383.html
SOURCE Frost & Sullivan